TY - JOUR
T1 - Effects of mesoporous silica nanoparticles upon the function of mammalian sperm in vitro
AU - Barkalina, Natalia
AU - Jones, Celine
AU - Kashir, Junaid
AU - Coote, Siobhan
AU - Huang, Xinyue
AU - Morrison, Rachel
AU - Townley, Helen
AU - Coward, Kevin
N1 - Funding Information:
Conflict of interest, disclosures, financial support information: the authors report no conflict of interest, and have nothing to disclose. NB is funded by the Clarendon, Scatcherd European, and Cyril & Phillis Long Schemes . The project is also funded by the Nuffield Department of Obstetrics and Gynaecology, and an EPSRC Pathways to Impact Award (University of Oxford) .
PY - 2014/5
Y1 - 2014/5
N2 - Nanomaterial-mediated delivery represents a promising technique for reproductive biology with a potential to improve the safety and efficacy of existing methodologies, including experimental gene therapy and sperm-mediated gene transfer. Mesoporous silica nanoparticles (MSNPs) have been characterised as a powerful and safe delivery tool, rendering them an excellent candidate for use in reproductive research. However, their effects upon mammalian gametes with highly specialised structure and functionality remain untested. Here, we show for the first time, that spherical MSNPs with hexagonal pore symmetry, functionalised with polyethileneimine and aminopropyltriethoxysilane, and optionally loaded with two common types of cargo (nucleic acid/protein), form strong associations with boar sperm following incubation in vitro and do not exert negative effect upon the main parameters of sperm function, including motility, viability, acrosomal status and DNA fragmentation index. Our findings provide a rationale for the use of MSNPs for the transfer of investigative, diagnostic and/or therapeutic compounds into mammalian sperm. From the Clinical Editor: Functionalized mesoporous silica nanoparticles (MSNPs) are demonstrated as efficient agents for the transfer of investigative, diagnostic, and/or therapeutic compounds into mammalian sperm. This promising technique has the potential to improve the safety and efficacy of existing methodologies, including experimental gene therapy and sperm-mediated gene transfer.
AB - Nanomaterial-mediated delivery represents a promising technique for reproductive biology with a potential to improve the safety and efficacy of existing methodologies, including experimental gene therapy and sperm-mediated gene transfer. Mesoporous silica nanoparticles (MSNPs) have been characterised as a powerful and safe delivery tool, rendering them an excellent candidate for use in reproductive research. However, their effects upon mammalian gametes with highly specialised structure and functionality remain untested. Here, we show for the first time, that spherical MSNPs with hexagonal pore symmetry, functionalised with polyethileneimine and aminopropyltriethoxysilane, and optionally loaded with two common types of cargo (nucleic acid/protein), form strong associations with boar sperm following incubation in vitro and do not exert negative effect upon the main parameters of sperm function, including motility, viability, acrosomal status and DNA fragmentation index. Our findings provide a rationale for the use of MSNPs for the transfer of investigative, diagnostic and/or therapeutic compounds into mammalian sperm. From the Clinical Editor: Functionalized mesoporous silica nanoparticles (MSNPs) are demonstrated as efficient agents for the transfer of investigative, diagnostic, and/or therapeutic compounds into mammalian sperm. This promising technique has the potential to improve the safety and efficacy of existing methodologies, including experimental gene therapy and sperm-mediated gene transfer.
KW - Delivery
KW - Mesoporous silica
KW - Nanoparticles
KW - Sperm
KW - Toxicity
UR - http://www.scopus.com/inward/record.url?scp=84900304116&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2013.10.011
DO - 10.1016/j.nano.2013.10.011
M3 - Article
C2 - 24200525
AN - SCOPUS:84900304116
SN - 1549-9634
VL - 10
SP - 859
EP - 870
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
IS - 4
ER -